Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoVue pulmonary hemodynamics safety
NCT01306292Phase 2Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Apr 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary hypertension (PH) comparing SonoVue with Placebo (2 arms). Primary endpoints: Systolic Pulmonary Artery Pressure, Diastolic Pulmonary Artery Pressure and 1 more. Started Apr 2011; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01306292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01306292.